Search Report
Home   About Us   Press Room   Custom Research   Research Store   Contact Us
Press Releases

 

Biochemical Testing Leading the Indian Diagnostics Market

Feb 13, 2011
Share |
 
Indian diagnostics market has been experiencing stupendous growth for the past few years due to the rising health consciousness of the people and high prevalence of diseases. There is a major focus on enhancing the accuracy of disease diagnosis to support the medical staff in providing the required treatment. Better financial conditions of the Indian population and rising healthcare expenditure are also important driving factors. Thus, Indian diagnostics market is expected to grow at a CAGR of over 22% during 2010-2012, as per our new report Indian Diagnostic Market Analysis”.
 
The report clearly indicates the vast potential held by the biochemical and hematology based devices & services. Besides, we have found that the Point of Care (POC) diagnosis is the leading driving factor for the industry. These highly precise and intricate tests provide a thorough analysis of the patient’s condition within a small time period. The diagnostic devices and services being offered in the country are increasingly matching up with the international standards, with more companies venturing into the field.
 
Our team of experts has categorically enumerated the prevailing segmentation of India’s diagnostics market. Hematology, immunology, microbiology, and urinalysis are some of the other segments that have appeared as the focus of the diagnostics industry. Moreover, the cost analysis presented in the report offers the financial outlook of the diagnostics market.
 
Indian Diagnostic Market Analysis also covers competitive analysis of the industry, with a detail account of all the major players. Additionally, the report explains the regulatory environment regarding the diagnostics industry in the country. Moreover, the prevailing trends and the future driving trends in the field have been considered, while studying the overall market scenario. The research work done in the report will help consultants, industry analysts, and vendors to get an in-depth knowledge of the current, past, and future performance of the industry.

For more information visit: http://www.rncos.com/Report/IM242.htm

Related Press Releases:
» US Generic Drugs to Grow Strongly in Future
» FDI Fuelling Growth of Hospital Services in India
» Indian Diagnostic Market Poised to Grow at 16% CAGR
» Next-Generation Sequencing Market to Touch US$ 2 Billion-Mark by 2015
» European Regenerative Medicine Market worth US$ 2.2 Billion in 2010
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Phone : +91 (120) 4224700/01/02/03
Fax : +91 (120) 4224707

Copyright © 2011, RNCOS, 2002-2011

Home
About Us
Careers
Request a Quote
Discounted Reports
Contact Us
Add URL
FAQ
Upcoming Reports